VRTX: Vertex Pharmaceuticals Incorporated Stock

by  •  • Comments Off on VRTX: Vertex Pharmaceuticals Incorporated Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 127,324.12
Enterprise Value ($M) 121,208.22
Book Value ($M) 16,409.60
Book Value / Share 63.90
Price / Book 7.76
NCAV ($M) 3,472.80
NCAV / Share 13.52
Price / NCAV 36.66

Profitability (mra)
Return on Invested Capital (ROIC) -0.03
Return on Assets (ROA) -0.02
Return on Equity (ROE) -0.03

Liquidity (mrq)
Quick Ratio 2.35
Current Ratio 2.69

Balance Sheet (mrq) ($M)
Current Assets 9,596.40
Assets 22,533.20
Liabilities 6,123.60
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 11,020.10
Operating Income 4,603.80
Net Income -535.60
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -492.60
Cash from Investing -3,770.00
Cash from Financing -1,494.90

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Capital World Investors 11.20 10.95
02-12 13G/A Fmr Llc 3.60 -28.97

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2024 ☐ TRANSITION REPORT PURSUANT TO

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-15 254,367 822,399 30.93
2025-04-14 286,886 919,847 31.19
2025-04-11 272,756 1,177,115 23.17
2025-04-10 640,822 1,866,221 34.34

(click for more detail)

Similar Companies
VIGL – Vigil Neuroscience, Inc. VIR – Vir Biotechnology, Inc.
VOR – Vor Biopharma Inc. VTRS – Viatris Inc.
VTYX – Ventyx Biosciences, Inc.


Financial data and stock pages provided by
Fintel.io